Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHISX vs. QAAGZX: which is better?

Bottom line

SHISX vs QAAGZX: the short answer

SHISX (Blackrock Health Sciences Opportunities Portfolio) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.

QAAGZX is cheaper at 0.86% vs 1.16% — a difference of $30 a year per $10,000 invested.

Over five years, SHISX returned +5.5% a year vs +4.1% for QAAGZX.

Updated Nov 19, 2026

SHISX vs QAAGZX side by side

SHISXQAAGZX
TypeMutual fundETF
Fund familyBlackRockT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.16%0.86%
Annual cost per $10k$116$86
10-yr cost on $10k (prospectus)$1,409$1,061
Max front load—None
12b-1 fee0.25%0%
1-yr return+15.9%+18.1%
5-yr return (annualized)+5.5%+4.1%
10-yr return (annualized)+9.5%+9.0%
Best quarter+17.5%+23.4%
Worst quarter−11.5%−15.8%
Net assets (fund)$5.9B$751.7M
Number of holdings155277
Portfolio turnover49%65%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSHISXQAAGZXDifference
2025+15.9%+18.1%−2.2%
2024+3.8%+1.7%+2.1%
2023+3.5%+3.0%+0.6%
2022−6.0%−12.5%+6.5%
2021+11.7%+13.1%−1.4%
2020+19.4%+29.6%−10.2%
2019+25.3%+29.0%−3.7%
2018+8.0%+1.1%+6.8%
2017+24.8%+27.6%−2.8%
2016−6.1%−10.5%+4.4%

Source: Fund prospectus bar charts

Holdings overlap

14 of SHISX's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingSHISXQAAGZX
Eli Lilly & Company12.29%14.06%
Johnson & Johnson8.77%6.64%
Unitedhealth Group Inc6.10%5.88%
Merck & Company Inc4.94%4.00%
Gilead Sciences Inc4.19%2.79%
Abbvie Inc3.94%5.12%
Amgen Inc3.37%1.80%
Thermo Fisher Scientific Inc3.02%2.53%
Vertex Pharmaceuticals Inc2.74%2.26%
Danaher Corp2.00%1.44%
Abbott Laboratories1.97%1.91%
Intuitive Surgical Inc1.95%1.89%
Elevance Health Inc1.56%1.54%
Stryker Corp1.15%1.78%

Source: SEC Form N-PORT

SHISX top 10

  1. Eli Lilly & Company — 12.29%
  2. Johnson & Johnson — 8.77%
  3. Unitedhealth Group Inc — 6.10%
  4. Merck & Company Inc — 4.94%
  5. Gilead Sciences Inc — 4.19%
  6. Abbvie Inc — 3.94%
  7. Amgen Inc — 3.37%
  8. Thermo Fisher Scientific Inc — 3.02%
  9. Vertex Pharmaceuticals Inc — 2.74%
  10. Pfizer Inc — 2.61%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between SHISX and QAAGZX?
SHISX (Blackrock Health Sciences Opportunities Portfolio) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds. QAAGZX is cheaper at 0.86% vs 1.16% — a difference of $30 a year per $10,000 invested.
Which is cheaper, SHISX or QAAGZX?
QAAGZX has the lower expense ratio (0.86%).
Should I own both SHISX and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.